comparemela.com

Latest Breaking News On - Harrow health stock down - Page 1 : comparemela.com

Harrow Health, Inc. (NASDAQ:HROW) Major Shareholder Opaleye Management Inc. Buys 29,400 Shares

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) major shareholder Opaleye Management Inc. purchased 29,400 shares of Harrow Health stock in a transaction dated Friday, April 19th. The shares were acquired at an average cost of $10.56 per share, for a total transaction of $310,464.00. Following the transaction, the insider now directly owns 3,775,000 shares […]

Craig-hallum
Institutional-trading-of-harrow-health
Eton-pharmaceuticals-inc
Harrow-health
Envestnet-asset-management-inc
Surface-ophthalmics-inc
Securities-exchange-commission
Nasdaq
Wasatch-advisors-inc
Opaleye-management-inc
Harrow-health-inc
Prelude-capital-management

Short Interest in Harrow Health, Inc. (NASDAQ:HROW) Declines By 20.0%

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) saw a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 4,890,000 shares, a decline of 20.0% from the November 15th total of 6,110,000 shares. Based on an average daily trading volume, of 682,900 shares, the days-to-cover […]

Zurcher-kantonalbank-zurich-cantonalbank
Markl-baum
Harrow-health-inc
Eton-pharmaceuticals-inc
News-ratings-for-harrow-health-daily
Opaleye-management-inc
Pharmaceuticals-inc
Allspring-global-investments-holdings
Harrow-health-stock-down
Northwestern-mutual-wealth-management-co
Nasdaq
Securities-exchange-commission

Harrow Health, Inc. (NASDAQ:HROW) Position Trimmed by Invictus Private Wealth LLC

Invictus Private Wealth LLC lowered its stake in Harrow Health, Inc. (NASDAQ:HROW – Free Report) by 17.4% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 639,316 shares of the company’s stock after selling 134,806 shares during the period. Harrow Health makes up about 1.6% […]

Markl-baum
Martina-makary
Zurcher-kantonalbank-zurich-cantonalbank
Securities-exchange-commission
Quarter-for-harrow-health
News-ratings-for-harrow-health-daily
Pharmaceuticals-inc
Marshall-wace
Eton-pharmaceuticals-inc
Mendota-financial-group
Harrow-health
Insider-transactions-at-harrow-health

Q2 2023 EPS Estimates for Harrow Health, Inc. Raised by B. Riley (NASDAQ:HROW)

Q2 2023 EPS Estimates for Harrow Health, Inc. Raised by B. Riley (NASDAQ:HROW)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Zurcher-kantonalbank-zurich-cantonalbank
Dorsey-wright-associates
Surface-ophthalmics-inc
Harrow-health
Harrow-health-company-profile
Tower-research-capital
Harrow-health-inc
Northwestern-mutual-wealth-management-co
Institutional-investors-weigh-in-on-harrow-health
Pharmaceuticals-inc
Harrow-health-stock-down
Nasdaq

Harrow Health, Inc. (NASDAQ:HROW) Sees Significant Growth in Short Interest

Harrow Health, Inc. (NASDAQ:HROW – Get Rating) was the target of a significant growth in short interest in May. As of May 31st, there was short interest totalling 2,890,000 shares, a growth of 30.8% from the May 15th total of 2,210,000 shares. Based on an average daily trading volume, of 455,200 shares, the days-to-cover ratio […]

Barclays-plc
Eton-pharmaceuticals-inc
Surface-ophthalmics-inc
Pharmaceuticals-inc
Institutional-investors-weigh-in-on-harrow-health
Mendota-financial-group
Harrow-health-company-profile
Nasdaq
Harrow-health-stock-down
News-ratings-for-harrow-health-daily
Jump-financial

vimarsana © 2020. All Rights Reserved.